Amlitelimab (Anti-TNFSF4 / OX40L / CD252)
Amlitelimab (Anti-TNFSF4 / OX40L / CD252) (A2762-GRP)
Products
Description
Amlitelimab (Anti-TNFSF4 / OX40L / CD252) is a nondepleting IgG4 human anti-OX40L monoclonal antibody with the potential to treat atopic dermatitis. MW: 145.94 kD.
Specifications
| Manufacturer | Selleck Chemicals LLC |
|---|---|
| Manufacturer Cat# | A2762 |
| Target | CD markers |